Illumina's Q4 2015 Revenues Climb 15 Percent | GenomeWeb

This story has been updated to include comments made from Illumina management during a conference call. 

NEW YORK (GenomeWeb) – Illumina reported after the close of the market on Tuesday that its 2015 fourth quarter revenues were up 15 percent over Q4 2014.

The San Diego-based genetic analysis products firm reported total Q4 revenues of $591.5 million compared to $512.4 million in Q4 2014, beating analysts' average estimate of $585.2 million. On a constant currency basis, its revenues increased 19 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.